MedPath

ImprimisRx NJ, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

17

FDA:17

Drug Approvals

Tim-Dor-Lat

Approval Date
May 8, 2018
FDA

Brim-Dor PF

Approval Date
May 8, 2018
FDA

Latanoprost PF

Approval Date
May 8, 2018
FDA

DexMoxiKetor PF

Approval Date
May 8, 2018
FDA

Dorzolamide PF

Approval Date
May 8, 2018
FDA

Dex-Moxi PF

Approval Date
May 8, 2018
FDA

Tim-Brim-Dor-Lat

Approval Date
May 8, 2018
FDA

Tim-Dor PF

Approval Date
May 8, 2018
FDA

Tim-Lat -PF

Approval Date
May 8, 2018
FDA

Prednisolone Acetate PF

Approval Date
May 8, 2018
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

AAO 2024 Highlights: Aging Clinicians, Presbyopia Drop, Modern Anesthesia, and AMD Advancements

Alfredo Sadun, MD, addressed the challenges of aging clinicians in ophthalmology, highlighting the complexities of assessing competency and avoiding ageism.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.